What it is
Regulatory status: dietary supplement
At a glance
What it is, why people use it, the evidence, and what to know before trying it.
Why people use it
- **HbA1c and plasma glucose in type 2 diabetes** (HbA1c, FPG, 2-h postprandial glucose).
- **Lipids** (LDL-C, total cholesterol, triglycerides, HDL-C) in dyslipidemia or T2D.
- **PCOS** (HOMA-IR, androgens / SHBG, waist, ovulation / IVF live birth).
- **NAFLD** (hepatic fat by 1H-MRS or ultrasound; ALT / AST / GGT).
- **Weight / BMI / waist** as a metabolic side-effect or a primary obesity claim.
- **“As good as metformin”** — treated here as its own claim, not as proof of the glucose claim.
- **Better GI tolerance than metformin** — a tolerability claim, not a benefit.
Evidence at a glance
At the **studied dose** — berberine HCl **500 mg BID or TID (1.0–1.5 g/day) for 8–16 weeks**, mostly in Chinese adults with T2D or dyslipidemia — there is a **real, replicated human signal**: HbA1c down about **0.4–0.7%** vs placebo/lifestyle, LDL-C down about **0.4–0.5 mmol/L**, TG down about **0.3 mmol/L**. That signal survives several metas (Dong 2012, Guo 2021, Blais 2023, Wang 2024) and one proper multi-centre RCT (Zhang 2008). Certainty is **moderate for “some glycemic and lipid effect at gram-doses in those populations”** and **low** once you ask about durability past 3 months, non-Asian patients, or hard outcomes.